ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

PLUR Pluri Inc

5.75
0.00 (0.00%)
Última actualización: 08:30:24
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pluri Inc PLUR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 5.75 08:30:24
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.75 5.75 5.75 5.75
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00GLOBEUnleashing the Power of MAIT Cells: Pluri Launches Novel..
08/4/202406:00GLOBEBreakthrough in Immune Cell Expansion: Pluri Granted U.S..
28/3/202406:15GLOBEPluri’s Business Verticals Gain Traction in Global Markets;..
27/3/202406:00GLOBEPluri Inc. Announces 1-for-8 Reverse Share Split
21/3/202406:00GLOBEPluri’s Sustainable Cell-Based Coffee Addresses Critical..
19/3/202403:00GLOBEEngage with Pluri's Talent: Exciting Conference Appearances..
14/3/202406:00GLOBEPluri Selected as CDMO by Remedy Cell for Cell-Derived..
11/3/202406:00GLOBEPluri™ Receives First-Ever Patent Approval for 3D Bioreactor..
06/3/202406:00GLOBEPluri Inc. Announces Appointment of Jim Roosevelt, Jr. to..
28/2/202406:00GLOBEPluri’s Innovation Across Various Industries: CEO Updates on..
14/2/202416:43EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
13/2/202415:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202415:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202406:00EDGAR2Form 8-K - Current report
23/1/202401:00GLOBEStep into the Future: Pluri Launches Sustainable Cell-Based..
08/1/202407:00EDGAR2Form 8-K - Current report
21/12/202306:00GLOBEPluri and Bar-Ilan University to Develop PLX Cells for the..
13/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/10/202315:01EDGAR2Form 8-K - Current report
15/9/202315:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/9/202315:07EDGAR2Form S-3/A - Registration statement under Securities Act of..
12/9/202315:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/8/202306:00GLOBEPluri’s PLX-R18 Increases Blood Cell Counts and Reduces Need..
13/7/202301:00GLOBEPluri Announces Appointment of Entrepreneur Lorne Abony to..
11/7/202301:00GLOBEU.S. National Institutes of Health to Fund $4.2 Million..

Su Consulta Reciente

Delayed Upgrade Clock